However, the lncRNAs reported in our study share less than 30% TTI with Snhg14, which is overexpressed in several cancers and potentiates tumor progression, in humans, by serving as a sponge (endogenous competitor RNA) for multiple microRNAs [46–48]. The gene discussed is SNHG14; the disease is cancer.